收费类受体-2在心肌梗塞后调节心室重塑
Tetsuro Shishido1, Naoki Nozaki, Seiji Yamaguchi
1First Department of Internal Medicine, Yamagata University School of Medicine, Yamagata, Japan.
Circulation
|December 6, 2003
概括
托尔类受体-2 (TLR-2) 淘汰小鼠在心肌梗塞后显示出改善的生存率和心脏纤维化减少. 这表明TLR-2在心脏病发作后的心室重塑中起着关键作用.
科学领域:
- 免疫学 免疫学 免疫学
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
背景情况:
- 收费类受体 (TLRs) 与介质素-1受体类似地发出信号,并被病原体激活.
- 内源信号,如热冲击蛋白和氧化应激可以激活TLRs,可能有助于心肌梗塞后的心脏重塑.
研究的目的:
- 研究托尔类受体-2 (TLR-2) 在心肌梗塞后心脏重塑中的作用.
主要方法:
- 在野生型 (WT) 和TLR-2淘汰赛 (KO) 小鼠中,通过冠状动脉绑定诱导心肌梗塞.
- 评估了存活率,心脏病发作大小,炎症细胞透,心肌纤维化,基因表达 (TGF-β1,原1型) 和左心室尺寸.
主要成果:
- 与心肌梗塞后4周的WT小鼠相比,TLR-2KO小鼠的生存率显著更高 (65%vs. 43%).
- 虽然心脏病发作的大小和炎症相似,但KO小鼠显示心肌纤维化减少,TGF-β1和原1型mRNA表达率降低,左心室尺寸更小,分数缩短改善.
- 这些功能性改善在手术后的第1周和第4周都被观察到.
结论:
- 在心肌梗塞后,TLR-2在心室重塑中发挥着重要作用.
- 准TLR-2可能提供一种治疗策略,以减轻不良的心脏重塑和改善心肌梗塞后的结果.
相关概念视频
Cardiac Catheterization II: Right Heart Catheterization
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


